PRE Stock Overview
Designs, develops, and sells medical diagnostic imaging systems in Italy.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 2/6 |
Past Performance | 0/6 |
Financial Health | 4/6 |
Dividends | 0/6 |
Rewards
Risk Analysis
Predict S.p.A. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | €0.70 |
52 Week High | €0.99 |
52 Week Low | €0.68 |
Beta | 0 |
11 Month Change | -13.94% |
3 Month Change | n/a |
1 Year Change | n/a |
33 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -23.48% |
Recent News & Updates
Recent updates
Shareholder Returns
PRE | IT Healthcare | IT Market | |
---|---|---|---|
7D | -12.0% | -5.0% | -2.1% |
1Y | n/a | -12.1% | 11.9% |
Return vs Industry: Insufficient data to determine how PRE performed against the Italian Healthcare industry.
Return vs Market: Insufficient data to determine how PRE performed against the Italian Market.
Price Volatility
PRE volatility | |
---|---|
PRE Average Weekly Movement | 8.8% |
Healthcare Industry Average Movement | 4.4% |
Market Average Movement | 4.2% |
10% most volatile stocks in IT Market | 7.0% |
10% least volatile stocks in IT Market | 2.4% |
Stable Share Price: PRE's share price has been volatile over the past 3 months compared to the Italian market.
Volatility Over Time: Insufficient data to determine PRE's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2008 | 18 | Angelo Gigante | www.predictcare.it/en |
Predict S.p.A. designs, develops, and sells medical diagnostic imaging systems in Italy. It offers ultrasound, X-ray, and magnetic resonance imaging equipment used in gynecology, cardiology, general imaging, and mammography. The company provides Mistral, a breath analysis diagnostic system; Optip, an integrated communication technology in remote that allows holopresence interaction for users by exchanging information content; and Aphel, a humanoid robot that assists patients and healthcare professionals in hospital.
Predict S.p.A. Fundamentals Summary
PRE fundamental statistics | |
---|---|
Market cap | €5.08m |
Earnings (TTM) | -€142.43k |
Revenue (TTM) | €6.73m |
0.8x
P/S Ratio-35.7x
P/E RatioIs PRE overvalued?
See Fair Value and valuation analysisEarnings & Revenue
PRE income statement (TTM) | |
---|---|
Revenue | €6.73m |
Cost of Revenue | €4.94m |
Gross Profit | €1.79m |
Other Expenses | €1.93m |
Earnings | -€142.43k |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -0.02 |
Gross Margin | 26.60% |
Net Profit Margin | -2.12% |
Debt/Equity Ratio | 41.1% |
How did PRE perform over the long term?
See historical performance and comparison